Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03560128 · ClinicalTrials.gov registry record · NA
Endocuff Vision Colonoscopy vs. AmplifEYE Colonoscopy
A NA study, sponsored by Indiana University.
- Completed
- Registry status
- NA
- Development phase
- 634
- Enrollment target
NCT03560128: Completed NA study, sponsored by Indiana University.
NCT03560128 is a NA study that has completed, run by Indiana University. The registered enrollment target is 634 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (55% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03560128, a NA study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- NA
- Development phase
- 634 participants
- Enrollment target
Study Summary
The study aims to compare the results between colonoscopies with two different attachments on the distal end of the colonoscope.
Primary Outcome
Comparison of the number of adenomas detected per colonoscopy between the Endocuff Vision Colonoscopy and the AmplifEYE colonoscopy.
Interventions
- DEVICE Endocuff Vision device
- DEVICE AmplifEYE device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 634 participants |
| Start Date | 2018-04-12 |
| Est. Completion | 2018-12-18 |
| Phase | NA |
What the finished NCT03560128 record still lists
NCT03560128 is an interventional study that assigns participants to a tested intervention. The registered 634 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (55% lower).
The record links to 0 conditions, and to 2 interventions - of which Endocuff Vision device is the first listed.
NCT03560128 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03560128 about?
NCT03560128 is a clinical study titled "Endocuff Vision Colonoscopy vs. AmplifEYE Colonoscopy". The study aims to compare the results between colonoscopies with two different attachments on the distal end of the colonoscope.
What is the current status of trial NCT03560128?
This trial is currently completed. It is a NA study. The enrollment target is 634 participants. The study started on 2018-04-12. Estimated completion is 2018-12-18.
What interventions are being tested in trial NCT03560128?
The interventions under investigation include: Endocuff Vision device (DEVICE), AmplifEYE device (DEVICE).
Who is sponsoring clinical trial NCT03560128?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03560128's enrollment target sits among peer trials
634 158th of 2000 higher than 1,842 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573027 · 634 participants · NA
Heart Disease of the Small Arteries in Women and Men
- NCT04108156 · 634 participants · Phase 3
A Study to Evaluate Efficacy, Safety & Pharmacokinetics of the Port Delivery System (PDS) With Ranibizumab in Participants With Diabetic Macular Edema (DME) Compared With Intravitreal Ranibizumab; A Substudy to Evaluate the Safety of Re-implanting the PDS With Ranibizumab in Participants With DME
- NCT07237295 · 634 participants · NA
CommunityRx-Kidney Health
- NCT03478826 · 635 participants
Creation of a Biospecimen Repository From Patients With Interstitial Lung Diseases (ILD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI